WATSON 254 (Brevicon ethinyl estradiol 0.035 mg / norethindrone 0.5 mg)

Generic Name: ethinyl estradiol/norethindrone

Pill imprint WATSON 254 has been identified as Brevicon ethinyl estradiol 0.035 mg / norethindrone 0.5 mg.

Brevicon is used in the treatment of acne; abnormal uterine bleeding; birth control; endometriosis; polycystic ovary syndrome (and more), and belongs to the drug classes contraceptives, sex hormone combinations. Not for use in pregnancy. Brevicon ethinyl estradiol 0.035 mg / norethindrone 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Brevicon

Generic Name:

ethinyl estradiol/norethindrone

Imprint:

WATSON 254

Strength:

ethinyl estradiol 0.035 mg / norethindrone 0.5 mg

Color:

Blue

Shape:

Round

Availability:

Prescription only

Drug Class:

Contraceptives
Sex hormone combinations

Pregnancy Category:

X - Not for use in pregnancy

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

52544-0254

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.